Nabumetone

Product NDC: 68462-358
11-digit product format: 684620358
Labeler code: 68462
Product ID: 68462-358_53eb632a-bd56-4079-b1cd-c0699b9bfc52
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Nabumetone
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Glenmark Pharmaceuticals Inc., USA
Application: ANDA078671
Marketing category: ANDA
Marketing start: 2008-03-01
Marketing end: 0000-00-00
Substance: NABUMETONE
Active strength: 500 mg/1
Pharmacologic classes: Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	68462-358		D	Discontinued by firm	2026-08-17
excluded package	package	68462-358	68462-358-01	D	Discontinued by firm	2026-08-17
excluded package	package	68462-358	68462-358-05	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68462-358-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68462-358-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68462-358-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68462-358-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68462-358-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68462-358-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68462-358-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68462-358-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68462-358-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68462-358-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68462-358-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68462-358-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68462-358-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68462-358-05	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68462-358-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68462-358-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68462-358-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68462-358-05	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68462-358-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68462-358-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68462-358-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68462-358-05	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68462-358-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68462-358-05	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078671-001	NABUMETONE	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07
A078671-002	NABUMETONE	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A078671-001	AB
A078671-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB		2008-03-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078671-001	NABUMETONE	500MG	TABLET / ORAL	AB		2008-03-07	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A078671-002	NABUMETONE	750MG	TABLET / ORAL	AB	RS	2008-03-07	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A078671-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078671-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078671-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078671-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078671-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078671-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078671-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078671-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078671-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078671-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078671-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078671-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078671-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078671-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078671-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078671-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078671-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078671-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078671-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078671-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078671-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078671-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078671-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078671-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078671-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078671-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078671-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078671-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078671-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A078671-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078671-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078671-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078671-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A078671-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078671-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A078671-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078671-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A078671-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078671-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A078671-002	AB	1	`bb7c543d1eb4…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9d4d18c4-d38e-37e1-df1c-ee38762bf8a5	Product name	4	20251024

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68462-358-01	EA - Each	68462-358	861f1f1a-afdb-4c93-9b7e-6a8a0fab2ae9	1	2012-07-24
68462-358-05	EA - Each	68462-358	051b203a-df0a-4ee5-836a-fab21fb81dc4	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [BLENHEIM PHARMACAL, INC.]	5
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
POLYETHYLENE GLYCOL 200	INACTIVE INGREDIENT	R95B8J264J	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [UNIT DOSE SERVICES]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]	3
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.]	2
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [PREFERRED PHARMACEUTICALS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [PHYSICIANS TOTAL CARE, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
NABUMETONE	ACTIVE INGREDIENT	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
NABUMETONE	ACTIVE MOIETY	LW0TIW155Z	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
POLYETHYLENE GLYCOL 200	INACTIVE INGREDIENT	R95B8J264J	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
POLYETHYLENE GLYCOL 200	INACTIVE INGREDIENT	R95B8J264J	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [RXCHANGE CO.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [PROFICIENT RX LP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nabumetone	NABUMETONE	Northwind Health Company, LLC	b088f564-43ff-8007-e053-2995a90ab012	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078671 application number: ANDA078671
Nabumetone	NABUMETONE	American Health Packaging	0653b873-b74b-4ec6-b112-675760703d91	2025-11-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078671 application number: ANDA078671
Nabumetone	NABUMETONE	PD-Rx Pharmaceuticals, Inc.	8f3c1b1d-2765-4cb5-92df-044b99339c92	2025-06-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078671 application number: ANDA078671
Nabumetone	NABUMETONE	Exelan Pharmaceuticals Inc.	16e76e29-9315-40c0-b1d6-8d91961063cf	2025-03-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078671 application number: ANDA078671
Nabumetone	NABUMETONE	Cipla USA Inc.	85954380-a520-46d7-89ac-e4b19d6e00a1	2025-03-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078671 application number: ANDA078671
Nabumetone	NABUMETONE	Advanced Rx of Tennessee, LLC	af9969df-ce14-c0bc-e053-2995a90a3f59	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 078671 application number: ANDA078671

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
LW0TIW155Z	NABUMETONE	42924-53-8	NABUMETONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
311892	nabumetone 500 MG Oral Tablet	PSN	9df9212a-cf34-42b4-bd84-796b9e981eb0	5
311892	nabumetone 500 MG Oral Tablet	PSN	a521e63f-9021-41a6-8f41-907b16caadd2	5
311893	nabumetone 750 MG Oral Tablet	PSN	a521e63f-9021-41a6-8f41-907b16caadd2	5
311892	nabumetone 500 MG Oral Tablet	SCD	9df9212a-cf34-42b4-bd84-796b9e981eb0	5
311892	nabumetone 500 MG Oral Tablet	SCD	a521e63f-9021-41a6-8f41-907b16caadd2	5
311893	nabumetone 750 MG Oral Tablet	SCD	a521e63f-9021-41a6-8f41-907b16caadd2	5
311892	nabumetone 500 MG Oral Tablet	PSN	1dd75aec-e84e-1eb3-e054-00144ff8d46c	2
311892	nabumetone 500 MG Oral Tablet	PSN	d6b3822b-8f14-4137-8d53-24863f4c605e	2
311892	nabumetone 500 MG Oral Tablet	PSN	4445f9d9-4e89-5d88-e054-00144ff8d46c	2
311892	nabumetone 500 MG Oral Tablet	PSN	87028b13-0aab-4e90-b92e-6b0c54e59bbb	2
311892	nabumetone 500 MG Oral Tablet	PSN	b52901fa-5f7e-418b-aae5-842da7610434	2
311893	nabumetone 750 MG Oral Tablet	PSN	b52901fa-5f7e-418b-aae5-842da7610434	2
311893	nabumetone 750 MG Oral Tablet	PSN	87028b13-0aab-4e90-b92e-6b0c54e59bbb	2
311892	nabumetone 500 MG Oral Tablet	SCD	1dd75aec-e84e-1eb3-e054-00144ff8d46c	2
311892	nabumetone 500 MG Oral Tablet	SCD	d6b3822b-8f14-4137-8d53-24863f4c605e	2
311892	nabumetone 500 MG Oral Tablet	SCD	b52901fa-5f7e-418b-aae5-842da7610434	2
311892	nabumetone 500 MG Oral Tablet	SCD	87028b13-0aab-4e90-b92e-6b0c54e59bbb	2
311892	nabumetone 500 MG Oral Tablet	SCD	4445f9d9-4e89-5d88-e054-00144ff8d46c	2
311893	nabumetone 750 MG Oral Tablet	SCD	87028b13-0aab-4e90-b92e-6b0c54e59bbb	2
311893	nabumetone 750 MG Oral Tablet	SCD	b52901fa-5f7e-418b-aae5-842da7610434	2
311892	nabumetone 500 MG Oral Tablet	PSN	415b168c-12c2-2777-e054-00144ff88e88	1
311892	nabumetone 500 MG Oral Tablet	PSN	e6a40890-d3ce-400c-a552-0d5ad28193c5	1
311893	nabumetone 750 MG Oral Tablet	PSN	e6a40890-d3ce-400c-a552-0d5ad28193c5	1
311892	nabumetone 500 MG Oral Tablet	SCD	415b168c-12c2-2777-e054-00144ff88e88	1
311892	nabumetone 500 MG Oral Tablet	SCD	e6a40890-d3ce-400c-a552-0d5ad28193c5	1
311893	nabumetone 750 MG Oral Tablet	SCD	e6a40890-d3ce-400c-a552-0d5ad28193c5	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
68462-358-01	68462035801	100 TABLET, FILM COATED in 1 BOTTLE (68462-358-01)	2008-03-01	0000-00-00	No	No	Current
68462-358-05	68462035805	500 TABLET, FILM COATED in 1 BOTTLE (68462-358-05)	2008-03-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Nabumetone Tablets USP	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2022-01-25	HUMAN PRESCRIPTION DRUG LABEL	4
Nabumetone 500mg tablet	Advanced Rx Pharmacy of Tennessee, LLC	2021-11-11	HUMAN PRESCRIPTION DRUG LABEL	3
NuDroxiPAK N-500 - NuCare Pharmaceuticals,Inc.	NuCare Pharmaceuticals,Inc.	2021-05-04	HUMAN PRESCRIPTION DRUG LABEL	2
Nabumetone Tablets USP	NuCare Pharmaceuticals,Inc.	2021-01-11	HUMAN PRESCRIPTION DRUG LABEL	4
Nabumetone Tablets USP	Proficient Rx LP	2021-01-01	HUMAN PRESCRIPTION DRUG LABEL	5
Nabumetone Tablets USP	Bryant Ranch Prepack	2020-11-11	HUMAN PRESCRIPTION DRUG LABEL	9
Nabumetone Tablets USP	Preferred Pharmaceuticals, Inc.	2020-07-28	HUMAN PRESCRIPTION DRUG LABEL	7
Nabumetone Tablets USP	REMEDYREPACK INC.	2020-05-15	HUMAN PRESCRIPTION DRUG LABEL	4
Nabumetone Tablets USP	A-S Medication Solutions	2020-02-24	HUMAN PRESCRIPTION DRUG LABEL	17
Nabumetone Tablets USP	Medsource Pharmaceuticals	2019-12-27	HUMAN PRESCRIPTION DRUG LABEL	2
NABUMETONE	Direct_Rx	2019-10-14	HUMAN PRESCRIPTION DRUG LABEL	2
Nabumetone Tablets USP	Lake Erie Medical DBA Quality Care Products LLC	2019-04-24	HUMAN PRESCRIPTION DRUG LABEL	3
NABUMETONE	DIRECT RX	2019-03-07	HUMAN PRESCRIPTION DRUG LABEL	2
Nabumetone Tablets USP	Glenmark Pharmaceuticals Inc., USA \| ASCENT PHARMACEUTICALS INC	2018-12-07	HUMAN PRESCRIPTION DRUG LABEL	4
Nabumetone Tablets USP	St.Mary's Medical Park Pharmacy \| St. Mary's Medical Park Pharmacy \| Glenmark Pharmaceuticals Inc., USA \| ASCENT PHARMACEUTICALS INC	2018-11-15	HUMAN PRESCRIPTION DRUG LABEL	5
Nabumetone Tablets USP	Unit Dose Services	2017-07-01	HUMAN PRESCRIPTION DRUG LABEL	5
Nabumetone Tablets USP	NuCare Pharmaceuticals, Inc.	2016-11-15	HUMAN PRESCRIPTION DRUG LABEL	1
Nabumetone Tablets USP	Blenheim Pharmacal, Inc.	2015-05-27	HUMAN PRESCRIPTION DRUG LABEL	5
Nabumetone Tablets USP	RxChange Co.	2014-11-13	HUMAN PRESCRIPTION DRUG LABEL	1
Nabumetone Tablets USP	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-07-01	HUMAN PRESCRIPTION DRUG LABEL	2
Nabumetone Tablets USP	Physicians Total Care, Inc.	2012-04-02	HUMAN PRESCRIPTION DRUG LABEL	2
Nabumetone Tablets USP	H.J. Harkins Company, Inc. \| Glenmark Generics Inc., USA \| Invagen Pharmaceuticals Inc.	2011-12-20	HUMAN PRESCRIPTION DRUG LABEL	2
Nabumetone Tablets USP	Rebel Distributors Corp.	2010-10-08	HUMAN PRESCRIPTION DRUG LABEL	2